Validation of days at home as an outcome measure after surgery: a prospective cohort study in Australia.

ABSTRACT:

Objective

To evaluate 'days at home up to 30 days after surgery' (DAH₃₀) as a patient-centred outcome measure.

Design

Prospective cohort study.

Data source

Using clinical trial data (seven trials, 2109 patients) we calculated DAH₃₀ from length of stay, readmission, discharge destination and death up to 30 days after surgery.

Main outcome

The association between DAH₃₀ and serious complications after surgery.

Results

One or more complications occurred in 263 of 1846 (14.2%) patients, including 19 (1.0%) deaths within 30 days of surgery; 245 (11.6%) patients were discharged to a rehabilitation facility and 150 (7.1%) were readmitted to hospital within 30 days of surgery. The median DAH₃₀ was significantly less in

SUBMITTER: Myles PS 

PROVIDER: S-EPMC5629653 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature